Standard Surfactants (BSE 526231)₹147.50+10.20%Commodity Chemicals
In the Mar 2026 quarter (standalone), Standard Surfactants reported sales of ₹73.96 Cr, up 55.8% from Mar 2025, and net profit of ₹2.51 Cr, up 93.1% year on year. For the year to Mar 2026, sales were ₹244 Cr and net profit ₹2.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.57 | 31.76 | 32.45 | 37.40 | 35.99 | 45.50 | 41.07 | 47.48 | 53.11 | 52.93 | 64.63 | 73.96 |
| Expenses | 28.71 | 30.37 | 32.05 | 36.90 | 35.32 | 45.43 | 40.88 | 44.05 | 51.78 | 51.48 | 62.53 | 69.10 |
| Operating Profit | 0.83 | 1.36 | 0.36 | 0.51 | 0.60 | 0.06 | 0.16 | 3.34 | 1.24 | 1.38 | 1.97 | 4.70 |
| OPM % | 2.8% | 4.3% | 1.1% | 1.3% | 1.6% | 0.1% | 0.4% | 7.0% | 2.3% | 2.6% | 3.1% | 6.3% |
| Other Income | 0.09 | 0.06 | 0.10 | 0.08 | 0.13 | 0.34 | 1.19 | −0.52 | 0.62 | 0.39 | 0.63 | 1.12 |
| Interest | 0.40 | 0.92 | −0.10 | −0.07 | 0.29 | 0.44 | 0.53 | 0.42 | 0.77 | 1.32 | 1.24 | 1.63 |
| Depreciation | 0.10 | 0.10 | 0.11 | 0.11 | 0.13 | 0.25 | 0.51 | 0.20 | 0.51 | 0.65 | 0.65 | 0.72 |
| Profit before tax | 0.45 | 0.41 | 0.46 | 0.56 | 0.34 | −0.26 | 0.34 | 2.19 | 0.59 | −0.19 | 0.74 | 3.50 |
| Tax % | −2.3% | 30.9% | −2.2% | 47.2% | 0.0% | −3.7% | 48.5% | 39.4% | 25.0% | −22.3% | 32.9% | 27.8% |
| Net Profit | 0.44 | 0.28 | 0.45 | 0.28 | 0.31 | −0.25 | 0.15 | 1.30 | 0.45 | −0.13 | 0.48 | 2.51 |
| EPS (Rs) | 0.55 | 0.36 | 0.57 | 0.36 | 0.40 | −0.32 | 0.20 | 1.60 | 0.57 | −0.18 | 0.60 | 3.06 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.10 | 55.10 | 87.09 | 117 | 83.19 | 92.09 | 125 | 152 | 131 | 170 | 244 | 245 |
| Expenses | 41.99 | 52.03 | 83.99 | 114 | 80.99 | 88.05 | 121 | 149 | 128 | 166 | 235 | 235 |
| Operating Profit | 2.01 | 2.01 | 2.01 | 3.01 | 2.01 | 4.01 | 4.01 | 3.01 | 3.01 | 4.01 | 9.01 | 9.29 |
| OPM % | 4.5% | 3.9% | 2.9% | 2.3% | 2.4% | 4.4% | 3.2% | 2.0% | 2.2% | 2.4% | 3.8% | 3.8% |
| Other Income | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 2.99 | 2.76 |
| Interest | 2.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.99 | 5.01 | 4.96 |
| Depreciation | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 2.01 | 2.53 |
| Profit before tax | 1.01 | 1.01 | 0.99 | 0.99 | 1.01 | 3.01 | 3.01 | 2.01 | 2.01 | 3.01 | 5.01 | 4.64 |
| Tax % | 33.0% | 34.0% | 3.0% | 32.0% | −5.0% | 30.0% | 22.9% | 25.0% | 20.0% | 40.0% | 29.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 0.99 | 1.99 | 2.99 | 3.31 |
| EPS (Rs) | 0.61 | 0.61 | 1.35 | 1.17 | 1.27 | 3.05 | 3.45 | 2.05 | 1.80 | 1.86 | 4.04 | 4.05 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 | 7.03 | 8.03 | 8.03 | 8.03 | 8.02 |
| Reserves | 4.98 | 4.98 | 5.98 | 6.98 | 6.99 | 7.98 | 9.97 | 13.96 | 16.96 | 20.00 | 21.00 | 23.94 |
| Borrowings | 7.99 | 10.00 | 14.98 | 17.00 | 18.01 | 18.99 | 21.98 | 20.97 | 25.98 | 33.04 | 56.07 | 68.01 |
| Other Liabilities | 8.04 | 6.03 | 4.02 | 8.04 | 9.04 | 7.04 | 8.04 | 10.05 | 13.07 | 12.07 | 15.07 | 30.15 |
| Total Liabilities | 28.03 | 29.03 | 32.00 | 38.04 | 41.06 | 41.03 | 47.01 | 51.01 | 64.04 | 72.14 | 100 | 131 |
| Fixed Assets | 8.02 | 8.03 | 7.02 | 7.02 | 7.03 | 7.02 | 6.02 | 7.02 | 7.02 | 6.02 | 30.11 | 45.12 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.06 | 13.05 | 0.00 |
| Investments | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.97 |
| Other Assets | 19.02 | 20.01 | 23.99 | 31.03 | 33.04 | 35.01 | 40.99 | 44.99 | 57.02 | 50.06 | 57.01 | 78.03 |
| Inventories | 2.75 | 3.56 | 2.50 | 4.27 | 4.79 | 3.24 | 7.98 | 7.82 | 8.20 | 6.96 | 10.50 | 17.25 |
| Trade receivables | 9.71 | 9.41 | 14.30 | 20.81 | 21.26 | 17.08 | 19.66 | 24.36 | 27.55 | 28.52 | 33.13 | 35.85 |
| Cash & equivalents | 1.26 | 1.76 | 1.02 | 2.39 | 3.09 | 8.95 | 6.45 | 5.18 | 11.41 | 0.83 | 1.34 | 4.43 |
| Total Assets | 28.03 | 29.03 | 32.00 | 38.04 | 41.06 | 41.03 | 47.01 | 51.01 | 64.04 | 72.14 | 100 | 131 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.01 | 3.01 | 0.00 | −1.01 | 2.01 | 4.01 | −4.01 | 1.01 | 0.00 | −2.01 | 2.01 | −3.01 |
| Cash from investing activity | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | −5.99 | 1.99 | 0.00 | −3.99 | −6.98 | −20.95 | −4.98 |
| Cash from financing activity | −4.01 | −3.01 | −1.01 | 1.01 | 0.00 | 1.01 | 1.01 | −2.01 | 6.01 | 8.02 | 19.03 | 10.02 |
| Net cash flow | 0.99 | 0.00 | 0.00 | 0.00 | 1.99 | −1.99 | 0.00 | −1.01 | 0.99 | −0.99 | 0.00 | 2.01 |
| Capex | 0.31 | 0.04 | 0.17 | 0.24 | 0.42 | 0.00 | 0.33 | 0.38 | 0.15 | 16.63 | 20.62 | 4.46 |
| Free cash flow | 4.01 | 3.01 | 0.00 | −1.01 | 2.01 | 4.01 | −4.01 | 1.01 | 0.00 | −19.03 | −19.01 | −7.01 |
| CFO / OP % | 166.1% | 173.1% | −4.0% | −24.9% | 88.1% | 218.1% | −87.9% | 61.1% | 27.1% | −55.9% | 60.1% | −19.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 66 | 77 | 94 | 86 | 65 | 74 | 76 | 70 | 65 | 78 | 70 | 52 |
| Inventory days | 22 | 35 | 19 | 21 | 17 | 17 | 37 | 25 | 21 | 21 | 25 | 29 |
| Days payable | 16 | 27 | 4 | 25 | 23 | 22 | 18 | 24 | 28 | 29 | 25 | 25 |
| Cash conversion cycle | 74 | 87 | 111 | 84 | 62 | 71 | 97 | 73 | 60 | 72 | 71 | 58 |
| Working capital days | 19 | 28 | 26 | 22 | 14 | 11 | 38 | 43 | 24 | 53 | 25 | 27 |
| ROCE % | 11.0% | 10.0% | 9.0% | 8.0% | 8.0% | 5.0% | 11.0% | 10.0% | 7.0% | 5.0% | 5.0% | 10.0% |
For the Mar 2026 quarter, Standard Surfactants reported sales of ₹73.96 Cr, up 55.8% year on year and net profit of ₹2.51 Cr, up 93.1% year on year. The operating margin was 6.3%.
Standard Surfactants' sales for the year to Mar 2026 were ₹244 Cr; over the last twelve months they were ₹245 Cr.
Net profit for the year to Mar 2026 was ₹2.99 Cr, and ₹3.31 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.05.
Standard Surfactants reported borrowings of ₹68.01 Cr at Mar 2026, against cash and equivalents of ₹4.43 Cr.
Cash from operations was −₹3.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.01 Cr.